McKesson, US58155Q1031

McKesson declares USD 0.94 dividend per McKesson stock

Published on 10/22/2026 at 12:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson stock trades at EUR 912.50 on October 22, 2026. Its USD 0.94 dividend is payable January 4, 2027.

Dividend and upcoming results

  • McKesson declared a USD 0.94 quarterly dividend on October 21, 2026.
  • Second-quarter fiscal 2027 results are scheduled for November 4, 2026.
  • McKesson stock trades at EUR 912.50 at 12:11 p.m. CEST at Lang & Schwarz on October 22, 2026.
Flatlay-Arrangement mit Aktienzertifikat und ISIN-Karte US58155Q1031 illustriert eine Investition in McKesson Corporation im Gesundheitswesen heute, Illustration mit AI erstellt.

McKesson (ISIN US58155Q1031) traded at EUR 912.50 at Lang & Schwarz on October 22, 2026, while the healthcare distributor's latest corporate action was a USD 0.94 quarterly dividend. The board declared the payment on October 21, 2026, and set January 4, 2027, as the payment date, according to McKesson.

Dividend keeps cash return steady

The 94-cent distribution is payable to shareholders of record on December 1, 2026. MarketBeat reported that the dividend had increased from USD 0.82 to USD 0.94 in the prior quarterly cycle, implying an annualized USD 3.76 payment at the latest rate.

The payout sits alongside McKesson's fiscal 2027 adjusted earnings-per-share guidance of USD 44.20 to USD 45.00. The company reaffirmed that range when it announced an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032, as Business Wire reported on October 1, 2026.

Three events shape the recent record

On August 5, 2026, McKesson reported fiscal first-quarter revenue of USD 105.38 billion and adjusted earnings per share of USD 9.93, versus consensus earnings per share of USD 9.56, according to MarketBeat. On October 1, 2026, the CVS agreement in principle extended the planned relationship through June 2032. On October 21, 2026, the board declared the USD 0.94 dividend.

What comes next for earnings?

McKesson will release second-quarter fiscal 2027 results after the market close on November 4, 2026, with an investor call scheduled for 4:30 p.m. ET, according to McKesson. The next dividend payment follows on January 4, 2027, giving investors two dated events for assessing the guidance range and cash distribution.

Stock price and company profile

McKesson's market capitalization was USD 120.1 billion at the close of October 20, 2026, while its 52-week high stood at USD 1,030.18. The company's latest annual figures showed fiscal 2026 revenue of USD 403.43 billion, up from USD 359.05 billion in fiscal 2025, and net income attributable to common shareholders of USD 4.76 billion versus USD 3.30 billion.

McKesson was trading at EUR 912.50 at Lang & Schwarz on October 22, 2026 at 12:11 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of McKesson stock.

McKesson stock facts

  • Company: McKesson Corporation
  • ISIN: US58155Q1031
  • WKN: 893953
  • Ticker: MCK
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 22, 2026, 12:11 p.m. CEST): EUR 912.50
  • Market capitalization: USD 120.1 billion (as of October 20, 2026)
  • Sector / Industry: Healthcare / Medical distribution

Market context: Market report S&P 500.

More news and analyses on McKesson stock

Disclaimer...
en | US58155Q1031 | MCKESSON | boerse | 70393142 | bgmi